Literature DB >> 2347295

The challenge of illicit drug addiction for general practice.

J Cohen1, A Schamroth.   

Abstract

Eighty-five drug misusers sought help and treatment from our central London practice in the 12 months between 1st November 1987 and 31st October 1988. They were all accepted for a short course of oral methadone reduction. At the end of the 12 months, according to the best information available from records, family, friends, neighbors, support agencies and patient reports, 19 (22%) were off all illicit drugs and 9 (16%) of those who had been unemployed at presentation had obtained regular employment. On average, our opiate misusers consumed 0.5 g of heroin daily at a daily street cost of approximately 40 pounds or 14,600 pounds annually. Sixty per cent of them admitted to financing their drug habit through criminal activities. Against the huge social cost of illicit drug misuse, the cost of providing primary health care to all these 85 addicts was 8% of each two doctors' consulting time at an annual cost of 2171 pounds per GP (25 pounds per hour of GP time). Thus for the methadone reduction programme for these 85 addicts to be judged effective based on cost alone, one would require a drug abstention ("success") rate of 0.003%.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2347295     DOI: 10.1016/0376-8716(90)90157-a

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  3 in total

1.  Use of general practice by intravenous heroin users on a methadone programme.

Authors:  E J Leaver; J Elford; J K Morris; J Cohen
Journal:  Br J Gen Pract       Date:  1992-11       Impact factor: 5.386

2.  Problem drug use in a central London general practice.

Authors:  J Cohen; A Schamroth; I Nazareth; M Johnson; S Graham; D Thomson
Journal:  BMJ       Date:  1992-05-02

3.  Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers.

Authors:  Stephen F Butler; Christine Benoit; Simon H Budman; Kathrine C Fernandez; Cynthia McCormick; Synne Wing Venuti; Nathaniel Katz
Journal:  Harm Reduct J       Date:  2006-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.